Literature DB >> 12585506

Respiratory effects of toluene diisocyanate in the workplace: a discussion of exposure-response relationships.

M Gerald Ott1, W F Diller, Athena T Jolly.   

Abstract

Toluene diisocyanate (TDI) is an important industrial intermediate used in manufacturing flexible polyurethane (PUR) foams, surface coatings, cast elastomers, sealants, and adhesives. In this review long-term trends in workplace exposures to TDI are assessed in both the producing and using industries, and respiratory health effects of TDI are evaluated in relation to workplace TDI concentrations. The key respiratory health effects associated with repeated or long-term TDI exposure are bronchial asthma and an accelerated rate of decline in lung function. In the early years of the industry, annual incidence rates of occupational asthma (OA) due to TDI ranged from 1% to as high as 5 to 6%, depending on the extent of engineering and work practice controls in the various workplaces. Since the mid-1970s, annual OA incidence rates have been <1%, where 8 h TDI concentrations have been maintained below 5 ppb as determined by personal monitoring, even where short-termTDI concentrations above 20 ppb and less frequently above 40 ppb were routinely detected. In these latter settings, there is evidence that the majority of OA cases may be attributable to TDI concentrations well above 20 ppb associated with overexposure incidents. Further study is needed regarding the role of such incidents in inducing respiratory sensitization. Cross-sectional and longitudinal studies of lung function have indicated that continued exposure after development of work-related respiratory symptoms can lead to transient or accelerated fixed declines in forced expiratory volume in 1 sec (FEV1). These findings are congruent with the FEV1 declines demonstrated in general population studies of persons with persistent bronchial hyperresponsiveness or nonoccupational asthma. More recent longitudinal studies in settings with ongoing medical surveillance have provided no consistent evidence of accelerated FEV1 loss among employees exposed up to 5 ppb TDI on an 8 h time-weighted average basis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12585506     DOI: 10.1080/713611031

Source DB:  PubMed          Journal:  Crit Rev Toxicol        ISSN: 1040-8444            Impact factor:   5.635


  12 in total

1.  Medical Monitoring for Occupational Asthma Among Toluene Diisocyanate Production Workers in the United States.

Authors:  Laura D Cassidy; Brent Doney; Mei Lin Wang; Laura Kurth; Patrick R Conner; James J Collins; Michael Carson; Don Molenaar; Carrie A Redlich; Eileen Storey
Journal:  J Occup Environ Med       Date:  2017-12       Impact factor: 2.162

2.  Early onset of neurological symptoms in fragile X premutation carriers exposed to neurotoxins.

Authors:  Ripon Paul; Isaac N Pessah; Louise Gane; Michele Ono; Paul J Hagerman; James A Brunberg; Flora Tassone; James A Bourgeois; Patrick E Adams; Danh V Nguyen; Randi Hagerman
Journal:  Neurotoxicology       Date:  2010-05-11       Impact factor: 4.294

3.  Identification of environmental factors that promote intestinal inflammation.

Authors:  Liliana M Sanmarco; Chun-Cheih Chao; Yu-Chao Wang; Jessica E Kenison; Zhaorong Li; Joseph M Rone; Claudia M Rejano-Gordillo; Carolina M Polonio; Cristina Gutierrez-Vazquez; Gavin Piester; Agustin Plasencia; Lucinda Li; Federico Giovannoni; Hong-Gyun Lee; Camilo Faust Akl; Michael A Wheeler; Ivan Mascanfroni; Merja Jaronen; Moneera Alsuwailm; Patrick Hewson; Ada Yeste; Brian M Andersen; Diana G Franks; Chien-Jung Huang; Millicent Ekwudo; Emily C Tjon; Veit Rothhammer; Maisa Takenaka; Kalil Alves de Lima; Mathias Linnerbauer; Lydia Guo; Ruxandra Covacu; Hugo Queva; Pedro Henrique Fonseca-Castro; Maha Al Bladi; Laura M Cox; Kevin J Hodgetts; Mark E Hahn; Alexander Mildner; Joshua Korzenik; Russ Hauser; Scott B Snapper; Francisco J Quintana
Journal:  Nature       Date:  2022-10-20       Impact factor: 69.504

Review 4.  Occupational asthma risk from exposures to toluene diisocyanate: A review and risk assessment.

Authors:  Robert D Daniels
Journal:  Am J Ind Med       Date:  2018-02-01       Impact factor: 2.214

5.  Incidence of Occupational Asthma and Exposure to Toluene Diisocyanate in the United States Toluene Diisocyanate Production Industry.

Authors:  James J Collins; Steve Anteau; Patrick R Conner; Laura D Cassidy; Brent Doney; Mei Lin Wang; Laura Kurth; Michael Carson; Don Molenaar; Carrie A Redlich; Eileen Storey
Journal:  J Occup Environ Med       Date:  2017-12       Impact factor: 2.162

6.  Opportunities and obstacles in translating evidence to policy in occupational asthma.

Authors:  Susan M Tarlo; Ahmed A Arif; George L Delclos; Paul Henneberger; Jenil Patel
Journal:  Ann Epidemiol       Date:  2017-03-31       Impact factor: 3.797

7.  Occupational airborne exposure, specific sensitization and the atopic status: evidence of a complex interrelationship.

Authors:  Xaver Baur; Liubov Barbinova
Journal:  J Occup Med Toxicol       Date:  2013-02-13       Impact factor: 2.646

Review 8.  Toluene diisocyanate (TDI) airway effects and dose-responses in different animal models.

Authors:  Thomas Schupp; Michael A Collins
Journal:  EXCLI J       Date:  2012-07-24       Impact factor: 4.068

9.  Is Isocyanate Exposure and Occupational Asthma Still a Major Occupational Health Concern? Systematic Literature Review.

Authors:  Elie Coureau; Luc Fontana; Céline Lamouroux; Carole Pélissier; Barbara Charbotel
Journal:  Int J Environ Res Public Health       Date:  2021-12-14       Impact factor: 3.390

10.  Risk Assessment for Toluene Diisocyanate and Respiratory Disease Human Studies.

Authors:  Robert M Park
Journal:  Saf Health Work       Date:  2020-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.